Komori
CellSource (4880) · RiskRestated

Product Liability for Cell-Processed Products, Medical Devices, Cosmetics and Other Products

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies
Product and Sold-Product Quality Defect, Quality Assurance and Product Liability RiskA theme 582 companies write about · 605 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2026: 11 of 57 companies on the "Worse" side.

125 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 194 companies compared. The sentences above are computed from all 194.Comparing 200 of the theme's 607 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「If a cell-processing product for which we provide contract processing services causes harm to a patient's health, or if an accident occurs due to defects or other issues with medical devices or cosmetics that we sell, we may be held liable under product liability law」

    Product liability risks relating to cell-processing products, medical devices and cosmetics remain ongoing.
  2. FY2021RestatedAnnual report

    「If a cell-processing product for which we provide contract processing services causes harm to a patient's health, or if an accident occurs due to defects or other issues with medical devices or cosmetics that we sell, we may be held liable under product liability law」

    Product liability risks relating to cell-processing products, medical devices and cosmetics remain ongoing.
  3. FY2020RestatedAnnual report

    「If a cell-processing product for which we provide contract processing services causes harm to a patient's health, or if an accident occurs due to defects or other issues with medical devices or cosmetics that we sell, we may be held liable under product liability law」

    Product liability risks relating to cell-processing products, medical devices and cosmetics remain ongoing.
  4. FY2019First statedAnnual report

    「If a cell-processing product for which we provide contract processing services causes harm to a patient's health, or if an accident occurs due to defects or other issues with medical devices, cosmetics or facial devices that we sell, we may be held liable under product liability law」

    Although we have insurance coverage for part of this risk, we also disclose that it may not fully cover the damages payable.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Product Liability for Cell-Processed Products, Medical Devices, Cosmetics and Other Products | CellSource Co.,Ltd. (4880) | Komori